Literature DB >> 14730703

CD44-independent hepatocyte growth factor/c-Met autocrine loop promotes malignant peripheral nerve sheath tumor cell invasion in vitro.

Weiping Su1, David H Gutmann, Arie Perry, Roger Abounader, John Laterra, Larry S Sherman.   

Abstract

Malignant peripheral nerve sheath tumors (MPNSTs) are invasive peripheral nerve neoplasms that express both the receptor tyrosine kinase c-Met and its ligand hepatocyte growth factor (HGF). The combined expression of these proteins has been implicated in tumor cell growth and metastasis. However, HGF/c-Met autocrine activity requires the presence of a serine protease, the HGF activator (HGFA), and, in some cells, the CD44 transmembrane glycoprotein. Here, we found that HGFA, HGF, c-Met, and CD44 are coexpressed in MPNSTs but their localization did not correlate with increased cell proliferation. The ST8814 MPNST cell line also expresses all of these proteins, can convert pro-HGF to active HGF, and exhibits constitutive c-Met phosphorylation. Blocking c-Met activity or expression inhibits the invasive behavior of these cells but not their proliferation. Interestingly, although a CD44 splice variant contributes to MPNST cell invasion and interacts with c-Met and HGF in ST8814 cells, it is not required for c-Met activation. These data indicate that an HGF/c-Met autocrine loop can promote MPNST invasion through a CD44-independent mechanism and suggest that c-Met, HGFA, and HGF are potential molecular targets to inhibit MPNST metastasis. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14730703     DOI: 10.1002/glia.10340

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  12 in total

1.  Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullin.

Authors:  Trent R Hummel; Walter J Jessen; Shyra J Miller; Lan Kluwe; Victor F Mautner; Margaret R Wallace; Conxi Lázaro; Grier P Page; Paul F Worley; Bruce J Aronow; Elizabeth K Schorry; Nancy Ratner
Journal:  Clin Cancer Res       Date:  2010-08-25       Impact factor: 12.531

2.  CD44 Transmembrane Receptor and Hyaluronan Regulate Adult Hippocampal Neural Stem Cell Quiescence and Differentiation.

Authors:  Weiping Su; Scott C Foster; Rubing Xing; Kerstin Feistel; Reid H J Olsen; Summer F Acevedo; Jacob Raber; Larry S Sherman
Journal:  J Biol Chem       Date:  2017-01-31       Impact factor: 5.157

3.  Clinical and molecular prognostic predictors of malignant peripheral nerve sheath tumor.

Authors:  Q Fan; J Yang; G Wang
Journal:  Clin Transl Oncol       Date:  2013-06-08       Impact factor: 3.405

4.  CD44 and p53 immunoexpression patterns in NF1 neoplasms - indicators of malignancy and infiltration.

Authors:  Nicole D Riddle; Lemuel Gorden; Mumtaz V Rojiani; Ardeshir Hakam; Amyn M Rojiani
Journal:  Int J Clin Exp Pathol       Date:  2010-06-12

5.  Activated MET is a molecular prognosticator and potential therapeutic target for malignant peripheral nerve sheath tumors.

Authors:  Keila E Torres; Quan-Sheng Zhu; Katelynn Bill; Gonzalo Lopez; Markus P Ghadimi; Xianbiao Xie; Eric D Young; Juehui Liu; Theresa Nguyen; Svetlana Bolshakov; Roman Belousov; Suizhau Wang; Guy Lahat; Jun Liu; Belinda Hernandez; Alexander J Lazar; Dina Lev
Journal:  Clin Cancer Res       Date:  2011-05-03       Impact factor: 12.531

6.  Abrogating drug resistance in malignant peripheral nerve sheath tumors by disrupting hyaluronan-CD44 interactions with small hyaluronan oligosaccharides.

Authors:  Mark G Slomiany; Lu Dai; Paul A Bomar; Thomas J Knackstedt; D Alex Kranc; Lauren Tolliver; Bernard L Maria; Bryan P Toole
Journal:  Cancer Res       Date:  2009-05-26       Impact factor: 12.701

7.  Gene expression profile identifies tyrosine kinase c-Met as a targetable mediator of antiangiogenic therapy resistance.

Authors:  Arman Jahangiri; Michael De Lay; Liane M Miller; W Shawn Carbonell; Yu-Long Hu; Kan Lu; Maxwell W Tom; Jesse Paquette; Taku A Tokuyasu; Sean Tsao; Roxanne Marshall; Arie Perry; Kirsten M Bjorgan; Myriam M Chaumeil; Sabrina M Ronen; Gabriele Bergers; Manish K Aghi
Journal:  Clin Cancer Res       Date:  2013-01-10       Impact factor: 12.531

8.  Neuregulin-1 beta and neuregulin-1 alpha differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cells.

Authors:  Jenell M Eckert; Stephanie J Byer; Buffie J Clodfelder-Miller; Steven L Carroll
Journal:  Glia       Date:  2009-11-01       Impact factor: 7.452

Review 9.  How does the Schwann cell lineage form tumors in NF1?

Authors:  Steven L Carroll; Nancy Ratner
Journal:  Glia       Date:  2008-11-01       Impact factor: 8.073

Review 10.  Recent Advances in the Diagnosis and Pathogenesis of Neurofibromatosis Type 1 (NF1)-associated Peripheral Nervous System Neoplasms.

Authors:  Jody F Longo; Shannon M Weber; Brittany P Turner-Ivey; Steven L Carroll
Journal:  Adv Anat Pathol       Date:  2018-09       Impact factor: 4.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.